InMode Ltd (FRA:154)
€ 17.575 -0.015 (-0.09%) Market Cap: 1.37 Bil Enterprise Value: 742.22 Mil PE Ratio: 10.50 PB Ratio: 2.01 GF Score: 64/100

Inmode Ltd at UBS Genomics 2.0 and MedTech Innovations Summit Transcript

Aug 12, 2021 / 07:00PM GMT
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

All right. Thanks for joining us for this next session. So we're going to have a 45-minute Q&A chat with management from InMode. Really pleased that you guys can join us here in person. Thanks a lot for coming, and welcome to the stage.

So for those of you who don't know going in order here, we've got Moshe Mizrahy, who's the CEO and Founder; Spero Theodorou, the CMO; Yair Malca, CFO; and Alon Yaari, who's the COO. So all the Cs are here, except for Shak. But I hope he's out selling boxes.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Anyway so guys, if you want to ask any questions, as always, just throw them up through the iPad here. And let me get started with a big picture question. Moshe, maybe you can just talk about your vision for InMode and touch on some of the founding principles that have now allowed you to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot